Funding
Funding not disclosed
Founders
Product
Problem
Traditional hormone testing for fertility clinics involves lengthy turnaround times for results, delaying critical treatment decisions. This delay can impact IVF outcomes and patient experience due to extended waiting periods and the need for follow-up calls.
Solution
Cyclic Diagnostics offers the Cyclic ProDX™ platform, a point-of-care solution for rapid, quantitative hormone analysis directly within fertility clinics. This system provides results in minutes, enabling clinicians to make timely and informed treatment decisions without requiring patients to wait for external laboratory reports. By streamlining the hormone monitoring process, the platform aims to optimize IVF protocols and enhance patient care. The technology utilizes an immunofluorescence platform for high-sensitivity assays, designed for ease of use and integration into existing clinic workflows.
Target Audience
The primary customers are fertility clinics and healthcare professionals involved in assisted reproductive technology (ART) and in vitro fertilization (IVF) treatments.
Features
- Cyclic ProDX™ platform for in-clinic, quantitative hormone analysis.
- Rapid assay turnaround time, delivering results in minutes.
- Utilizes immunofluorescence technology for high-sensitivity detection.
- Supports a range of fertility hormone tests including Progesterone, Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH), Anti-Müllerian Hormone (AMH), and Estradiol.
- CE-marked assays available for use in the UK and Europe.
- Designed for minimal hands-on time per sample (approximately 6 minutes).
- Intuitive user interface and straightforward testing protocol for ease of implementation.
- Validated performance against established diagnostic platforms.